AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $720,000 | +5.4% | 47,605 | -36.6% | 0.01% | 0.0% |
| Q1 2022 | $683,000 | +10.5% | 75,097 | -14.7% | 0.01% | +50.0% |
| Q4 2021 | $618,000 | +175.9% | 88,055 | +347.7% | 0.01% | +100.0% |
| Q3 2021 | $224,000 | -64.2% | 19,667 | -49.7% | 0.00% | -57.1% |
| Q2 2021 | $626,000 | +11.0% | 39,086 | +23.9% | 0.01% | -12.5% |
| Q1 2021 | $564,000 | +41.4% | 31,559 | +16.8% | 0.01% | -20.0% |
| Q2 2020 | $399,000 | +5.6% | 27,013 | +37.5% | 0.01% | -23.1% |
| Q3 2019 | $378,000 | -26.6% | 19,642 | +12.7% | 0.01% | -35.0% |
| Q2 2019 | $515,000 | – | 17,421 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 906,317 | $16,078,000 | 4.88% |
| Asymmetry Capital Management, L.P. | 85,834 | $1,523,000 | 3.39% |
| March Altus Capital Management LP | 30,962 | $549,000 | 3.23% |
| DAFNA Capital Management LLC | 165,669 | $2,939,000 | 2.92% |
| Partner Investment Management, L.P. | 49,726 | $882,000 | 1.33% |
| Boulegeris Investments, Inc. | 93,320 | $1,655,000 | 1.27% |
| PFM Health Sciences, LP | 2,218,198 | $39,351,000 | 1.11% |
| NORTHPOINTE CAPITAL LLC | 443,125 | $7,861,000 | 1.02% |
| HARVEY CAPITAL MANAGEMENT INC | 121,850 | $2,161,000 | 0.86% |
| Granite Point Capital Management, L.P. | 70,000 | $1,242,000 | 0.85% |